Trial
NCT03880474
Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Barinthus Biotherapeutics
Collaborators
Clinical Network Services (CNS) Pty Ltd
Condition
Influenza
Intervention
MVA-NP+M1
Why stopped
The trial is being stopped for futility. Season 2 cancelled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-26